SI1058687T1 - Nucleosides - Google Patents

Nucleosides

Info

Publication number
SI1058687T1
SI1058687T1 SI9930467T SI9930467T SI1058687T1 SI 1058687 T1 SI1058687 T1 SI 1058687T1 SI 9930467 T SI9930467 T SI 9930467T SI 9930467 T SI9930467 T SI 9930467T SI 1058687 T1 SI1058687 T1 SI 1058687T1
Authority
SI
Slovenia
Prior art keywords
nucleosides
hiv
compounds
independently
formula
Prior art date
Application number
SI9930467T
Other languages
English (en)
Slovenian (sl)
Inventor
Horst Whling
Xiao-Xiong Zhou
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA987267A external-priority patent/ZA987267B/xx
Priority claimed from PCT/SE1998/001467 external-priority patent/WO1999009031A1/en
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of SI1058687T1 publication Critical patent/SI1058687T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SI9930467T 1998-02-13 1999-02-12 Nucleosides SI1058687T1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9800452A SE9800452D0 (sv) 1998-02-13 1998-02-13 Antivirals
ZA987267A ZA987267B (en) 1997-08-15 1998-08-13 Nucleosides
PCT/SE1998/001467 WO1999009031A1 (en) 1997-08-15 1998-08-14 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
PCT/SE1999/000189 WO1999041268A1 (en) 1998-02-13 1999-02-12 Nucleosides
EP99932499A EP1058687B1 (en) 1998-02-13 1999-02-12 Nucleosides

Publications (1)

Publication Number Publication Date
SI1058687T1 true SI1058687T1 (en) 2004-02-29

Family

ID=20410196

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930467T SI1058687T1 (en) 1998-02-13 1999-02-12 Nucleosides

Country Status (22)

Country Link
EP (1) EP1058687B1 (da)
JP (1) JP4413427B2 (da)
KR (1) KR100565388B1 (da)
CN (1) CN1255422C (da)
AT (1) ATE256140T1 (da)
AU (1) AU732408B2 (da)
CA (1) CA2318975A1 (da)
DE (1) DE69913499T2 (da)
DK (1) DK1058687T3 (da)
ES (1) ES2211116T3 (da)
HK (1) HK1035907A1 (da)
HU (1) HUP0100879A3 (da)
IL (1) IL137605A (da)
MY (1) MY121813A (da)
NZ (1) NZ506033A (da)
PL (1) PL190284B1 (da)
PT (1) PT1058687E (da)
SE (1) SE9800452D0 (da)
SI (1) SI1058687T1 (da)
TR (1) TR200002318T2 (da)
WO (1) WO1999041268A1 (da)
ZA (1) ZA991148B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
EP1610797A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
EP1610781A1 (en) 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of tipranavir and a further antiretroviral compound
DE10321905A1 (de) * 2003-05-05 2004-12-09 Eberhard-Karls-Universität Tübingen Verwendung von Kombinationen aus Hemmern der reversen Transkriptase und Hemmern der viruscodierten DNA-Polymerase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
WO1992013561A1 (en) * 1991-02-08 1992-08-20 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives

Also Published As

Publication number Publication date
AU732408B2 (en) 2001-04-26
EP1058687A1 (en) 2000-12-13
HUP0100879A2 (hu) 2002-04-29
DK1058687T3 (da) 2004-03-15
ATE256140T1 (de) 2003-12-15
CN1290268A (zh) 2001-04-04
TR200002318T2 (tr) 2000-11-21
DE69913499T2 (de) 2004-10-28
KR100565388B1 (ko) 2006-03-30
EP1058687B1 (en) 2003-12-10
CN1255422C (zh) 2006-05-10
SE9800452D0 (sv) 1998-02-13
JP4413427B2 (ja) 2010-02-10
ES2211116T3 (es) 2004-07-01
MY121813A (en) 2006-02-28
HUP0100879A3 (en) 2002-08-28
DE69913499D1 (en) 2004-01-22
HK1035907A1 (en) 2001-12-14
WO1999041268A1 (en) 1999-08-19
NZ506033A (en) 2002-02-01
PT1058687E (pt) 2004-03-31
KR20010074428A (ko) 2001-08-04
PL190284B1 (pl) 2005-11-30
CA2318975A1 (en) 1999-08-19
JP2002503670A (ja) 2002-02-05
AU3281999A (en) 1999-08-30
IL137605A (en) 2006-12-31
ZA991148B (en) 1999-08-12

Similar Documents

Publication Publication Date Title
MY109743A (en) Pyrimidine derivatives.
CA2217952A1 (en) A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
GB0106661D0 (en) Pharmaceutically active compounds
MD1224C2 (ro) Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B
CA2368615A1 (en) Thiadiazolyl urea or thiourea derivatives for antiviral treatment
CA2343204A1 (en) Arylsulfonanilide ureas
KR0141913B1 (en) Anti-virus agents
BR0011521A (pt) Composto nucleósidos de purina de 4' -c-etinila
MX9707809A (es) Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres.
BG104250A (en) Levosimendan-containing composition for peroral administration
MY123083A (en) Acyclic nucleoside derivatives
CA2365495A1 (en) Viral treatment
ATE240339T1 (de) Nukleotidanaloga
CA2260060A1 (en) Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
DE69913499D1 (en) Nucleoside
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
TR199902019T2 (xx) �kame edilmi� tiazolidion' un haz�rlanmas� i�in proses.
CA2204204A1 (en) Carbohydrate derivatives
AP9801235A0 (en) Erythromycin derivatives.
SE9902268D0 (sv) Pharmaceutically active compounds
SE9902271D0 (sv) Pharmaceutically active compounds
ATE301997T1 (de) Antivirale therapie
AU1625795A (en) Imidazopyridine derivatives and process for preparing the same
CA2238516A1 (en) Acyclic nucleoside derivatives